Original Research
Accepted on 21 Mar 2025
WGCNA-ML-MR Integration: Uncovering Immune-Related Genes in Prostate Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1534612
Type at least 3 characters
1,859 articles
Original Research
Accepted on 20 Mar 2025
Lnc-CNNM3-DT as a Protective Factor in Cervical Cancer: Regulation of LIAS Expression and Intracellular Copper Levels
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1571788
Original Research
Accepted on 20 Mar 2025
FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1560008
- 263 views
Original Research
Accepted on 20 Mar 2025
Development and Validation of a Prognostic Model for Post-Surgical overall Survival in Asian Colon Cancer Patients: A real-world Population-based study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1541561
Case Report
Accepted on 20 Mar 2025
Case report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1527484
Case Report
Accepted on 20 Mar 2025
Unexpected outcomes of tislelizumab treatment in thoracic metastasis of malignant phyllodes tumors: a Case report and literature review
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1535653
Original Research
Accepted on 20 Mar 2025
Tumor-Associated Macrophages Correlate With Better Outcome in SHH Medulloblastoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1557313
Case Report
Published on 20 Mar 2025
Durable response to Olaparib in EGFR and somatic BRCA2-mutated lung adenocarcinoma with leptomeningeal metastases: a case report
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1512886
- 271 views
Review
Accepted on 19 Mar 2025
Enhancing Antitumor Immunity: The Role of Immune Checkpoint Inhibitors, Anti-Angiogenic Therapy, and Macrophage Reprogramming
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1526407
Brief Research Report
Published on 18 Mar 2025
Spatial genomics reveals cholesterol metabolism as a key factor in colorectal cancer immunotherapy resistance
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1549237
- 418 views
Review
Accepted on 17 Mar 2025
Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1545174
- 187 views
Review
Published on 17 Mar 2025
Exploring therapeutic applications of PTEN, TMPRSS2:ERG fusion, and tumour molecular subtypes in prostate cancer management
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1521204
- 435 views
Original Research
Published on 14 Mar 2025
A novel lactylation-related gene signature to predict prognosis and treatment response in lung adenocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1549724
- 520 views
Brief Research Report
Published on 13 Mar 2025
Mapping MAGE-A4 expression in solid cancers for targeted therapies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1484182
- 697 views
Review
Published on 13 Mar 2025
Immuno-inflammatory mechanisms in cardio-oncology: new hopes for immunotargeted therapies
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1516977
- 305 views
Review
Published on 11 Mar 2025
Therapies targeting triple-negative breast cancer: a perspective on anti-FGFR
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2024.1415820
- 446 views